AMBERFLOW Trademark

Trademark Overview

On Monday, November 19, 2018, a trademark application was filed for AMBERFLOW with the United States Patent and Trademark Office. The USPTO has given the AMBERFLOW trademark a serial number of 88200126. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by Amberstone Biosciences. The AMBERFLOW trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research services for medical purposes in the areas of antibody discovery, immunotherapeutic discovery, synthetic biology, and assay chemistry; pharmaceutical research services; laboratory research related to pharmaceuticals; pharmaceutical research services, namely, for developing pharmaceutical preparations derived from monoclonal antibody and immunotherapeutic screening and synthetic biology screening, directly from heterogenous immune cells, hybridoma, and engineered cell expression libraries
amberflow

General Information

Serial Number88200126
Word MarkAMBERFLOW
Filing DateMonday, November 19, 2018
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6760700
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Pseudo MarkAMBER FLOW
Goods and ServicesScientific research services for medical purposes in the areas of antibody discovery, immunotherapeutic discovery, synthetic biology, and assay chemistry; pharmaceutical research services; laboratory research related to pharmaceuticals; pharmaceutical research services, namely, for developing pharmaceutical preparations derived from monoclonal antibody and immunotherapeutic screening and synthetic biology screening, directly from heterogenous immune cells, hybridoma, and engineered cell expression libraries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 7, 2018
Primary Code042
First Use Anywhere DateWednesday, January 1, 2020
First Use In Commerce DateWednesday, January 1, 2020

Trademark Owner History

Party NameAmberstone Biosciences
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653
Party NameAmberstone Biosciences
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653
Party NameAmberstone Biosciences
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653

Trademark Events

Event DateEvent Description
Friday, May 26, 2023WITHDRAWAL OF ATTORNEY GRANTED
Friday, May 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, June 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 22, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 20, 2022USE AMENDMENT FILED
Wednesday, April 20, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, April 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 20, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 19, 2021SOU EXTENSION 5 GRANTED
Friday, November 12, 2021SOU EXTENSION 5 FILED
Friday, November 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 12, 2021TEAS EXTENSION RECEIVED
Thursday, May 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 25, 2021SOU EXTENSION 4 GRANTED
Tuesday, May 25, 2021SOU EXTENSION 4 FILED
Tuesday, May 25, 2021TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 23, 2020SOU EXTENSION 3 GRANTED
Friday, October 23, 2020SOU EXTENSION 3 FILED
Friday, October 23, 2020TEAS EXTENSION RECEIVED
Saturday, June 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 11, 2020SOU EXTENSION 2 GRANTED
Thursday, June 11, 2020SOU EXTENSION 2 FILED
Thursday, June 11, 2020TEAS EXTENSION RECEIVED
Tuesday, December 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 6, 2019SOU EXTENSION 1 GRANTED
Friday, December 6, 2019SOU EXTENSION 1 FILED
Friday, December 6, 2019TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 18, 2019ASSIGNED TO LIE
Monday, February 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 25, 2019EXAMINER'S AMENDMENT ENTERED
Monday, February 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 25, 2019EXAMINERS AMENDMENT E-MAILED
Monday, February 25, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, February 21, 2019ASSIGNED TO EXAMINER
Friday, December 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 22, 2018NEW APPLICATION ENTERED

Related Keywords

amberflow research pharmaceutical services biology from screening immunotherapeutic synthetic discovery antibody